InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-22.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Bigora Sian, Directeur du Développement. Officer active across 1 company, notably Processa Pharmaceuticals, Inc.. Cumulatively, 9 disclosures have been recorded. Split: 3 buys · 0 sell. Total volume traded: €14k. Activity tracked since 1 January 2026. The latest transaction was filed on 30 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Bigora Sian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
1,986 shares@ US$2.690.090% mcap100.0% of flowCommon StockSEC:0000897069-26-001000:0
Canonical exit: 29 Jul 2026 (T+90)
1,799 shares@ US$2.970.089% mcap49.8% of flowCommon StockSEC:0000897069-26-000904:0
Canonical exit: 14 Jul 2026 (T+90)
2,107 shares@ US$2.53533.7% of flowCommon StockSEC:0000897069-26-000743:0
Canonical exit: 29 Jun 2026 (T+90)
249 shares0Common StockSEC:0000897069-26-000218:0
15,059 sharesCommon StockSEC:0000897069-25-000789:0
1,675 sharesCommon StockSEC:0000897069-24-001615:0
1,675 sharesCommon StockSEC:0000897069-24-000919:0
7,601 sharesCommon StockSEC:0001567619-22-015305:0
7,601 sharesCommon StockSEC:0001567619-21-014751:0
9 of 9 declarations
About Bigora Sian
Bigora Sian is Chief Development Officer and appears in 9 filings in total. Across the 9 recent filings available, they concern Processa Pharmaceuticals, Inc., with EUR 13,694 of buys and EUR 0 of sells, mainly option exercises, between 2021-08-09 and 2026-05-01.
